Companies sponsors |
Gedeon Richter (relugolix) |
Others |
Department of Health and Social Care |
|
NHS England |
|
Welsh Government |
Patient carer groups |
FEmISA |
Professional groups |
Royal College of Physicians |
|
UK Clinical Pharmacy Association |
Associated guideline groups |
National Guideline Alliance |
Associated public health groups |
None |
Comparator companies |
Bayer (combined hormonal contraception, levonorgestrel, norethisterone) (confidentiality agreement signed, participating) |
|
Gedeon Richter (levonorgestrel) (confidentiality agreement signed, participating) |
|
Ipsen (triptorelin) (confidentiality agreement signed, participating) |
|
Takeda UK (leuprorelin) (confidentiality agreement signed, participating) |
|
AstraZeneca (goserelin) (confidentiality agreement not signed, not participating) |
|
Besins Healthcare (progesterone) (confidentiality agreement not signed, not participating) |
|
Lupin Healthcare (combined hormonal contraceptive) (confidentiality agreement not signed, not participating) |
|
Morningside Healthcare (combined hormonal contraception) (confidentiality agreement not signed, not participating) |
|
Mylan (combined hormonal contraception) (confidentiality agreement not signed, not participating) |
|
Novo Nordisk (oestradiol and norethisterone acetate) (confidentiality agreement not signed, not participating) |
|
Organon Pharma (combined hormonal contraceptive) (confidentiality agreement not signed, not participating) |
|
Pfizer (combined hormonal contraception, medroxyprogesterone, norethisterone) (confidentiality agreement not signed, not participating) |
|
Wockhardt UK (norethisterone) (confidentiality agreement not signed, not participating) |
General commentators |
All Wales Therapeutics and Toxicology Centre |
|
British National Formulary |
|
Department of Health, Social Services and Public Safety for Northern Ireland |
|
Healthcare Improvement Scotland |
|
Medicines and Healthcare products Regulatory Agency |
|
Scottish Medicines Consortium |
|
Welsh Health Specialised Services Committee |
Relevant research groups |
None |